연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1508 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Zang, Dae Young | Zang, DY | 21 | Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Jang, You Jin | Jang, YJ | 22 | Korea Univ Guro Hosp, Dept Surg, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Sul, Ji Young | Sul, JY | 23 | Chungnam Natl Univ Hosp, Dept Surg, Daejeon, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Jong Gwang | Kim, JG | 24 | Kyungpook Natl Univ, Dept Internal Med, Daegu, South Korea | J-5391-2012 | Kim, Dong-Wan | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Beom Su | Kim, BS | 25 | Univ Ulsan, Asan Med Ctr, Dept Surg, Seoul, South Korea | MBG-6090-2025 | Kim, Beomsu | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Beom, Seung-Hoon | Beom, SH | 26 | Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Internal Med, Seoul, South Korea | 0000-0001-7036-3753 | Beom, Seung-Hoon | ykkang@amc.seoul.kr; | |||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Hwang, Jun-Eul | Hwang, JE | 27 | Chonnam Natl Univ, Chonnam Natl Univ Hwasun Hosp, Dept Internal Med, Med Sch, Jeonnam, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Ryu, Seung Wan | Ryu, SW | 28 | Keimyung Univ, Dept Surg, Dongsan Med Ctr, Daegu, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kook, Myeong-Cherl | Kook, MC | 29 | Natl Canc Ctr, Ctr Gastr Canc Res Inst & Hosp, Grad Sch Canc Sci & Policy, Goyang, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Ryoo, Baek-Yeol | Ryoo, BY | 30 | Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Kim, Hyunki | Kim, H | 31 | Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea | F-4594-2014 | Kim, Hee | 0000-0003-2292-5584 | Kim, Hyunki | ykkang@amc.seoul.kr; | |
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Yoo, Moon-Won | Yoo, MW | 32 | Univ Ulsan, Asan Med Ctr, Dept Surg, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Lee, Nam Su | Lee, NS | 33 | Soon Chun Hyang Univ Hosp, Dept Internal Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Lee, Sang Ho | Lee, SH | 34 | Kosin Univ Gospel Hosp, Dept Surg, Busan, South Korea | ykkang@amc.seoul.kr; | |||||
| Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | Noh, Sung Hoon | Noh, SH | 35 | Yonsei Univ Hlth Syst, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea | 0000-0003-4386-6886 | Noh, Sung Hoon | ykkang@amc.seoul.kr; |
페이지 이동: